Ads
related to: nash liver disease
Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 12 hours ago...Ghent, Belgium – 6 June 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces data from its North American pivotal POSEIDON study of the alfapump®...
...Madrigal In Favor Of Eli Lilly And Company's GLP-1 Agonist For The Treatment Of Fatty Liver ...
Wccftech· 1 day agoStreet when it comes to thematic investing around anti-obesity GLP-1 drugs, with Novo Nordisk...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero...
Morningstar· 1 day agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO) and reminds investors ...
Viking Therapeutics reports promising data for liver disease drug | Invezz
Invezz· 2 days agoViking Therapeutics Inc (NASDAQ: VKTX) is in focus today after announcing positive Phase 2b data for its treatment for biopsy-confirmed non-alcoholic steatohepatitis (NASH ...
AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF...
WWTI Watertown· 6 days agoClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 25,...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoViking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoRNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6% CAGR- Exclusive Report by InsightAce Analytic Pvt. Ltd. PR Newswire JERSEY CITY, N.J., June 4, 2024 JERSEY CITY, N.J., June 4, 2024 /PRNewswire/ -- InsightAce Analytic
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNEW ORLEANS, June 04, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner,...
Viking's MASH drug scored where Madrigal's didn't, but shares fall on lack of direction
FierceBiotech· 2 days agoViking had already reported that the trial met its primary endpoint, with patients experiencing...
Can-Fite's Namodenoson gains FDA Fast Track for liver cancer By Investing.com
Investing.com· 1 day agoCan-Fite BioPharma (NYSE:CANF) Ltd. (NYSE American: CANF) (TASE:CANF), an Israeli biotech firm, has...
Ads
related to: nash liver disease
